These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 22414087)

  • 1. ChemoImmunoModulation: immune regulation by the antineoplastic chemotherapeutic agents.
    Shurin MR; Naiditch H; Gutkin DW; Umansky V; Shurin GV
    Curr Med Chem; 2012; 19(12):1792-803. PubMed ID: 22414087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic anti-cancer chemotherapy as an emerging concept.
    Haynes NM; van der Most RG; Lake RA; Smyth MJ
    Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicity.
    Mattarollo SR; Kenna T; Nieda M; Nicol AJ
    Int J Cancer; 2006 Oct; 119(7):1630-7. PubMed ID: 16646079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.
    Galluzzi L; Buqué A; Kepp O; Zitvogel L; Kroemer G
    Cancer Cell; 2015 Dec; 28(6):690-714. PubMed ID: 26678337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy.
    Wu J; Waxman DJ
    Cancer Lett; 2018 Apr; 419():210-221. PubMed ID: 29414305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy and Anticancer Immune Responses].
    Harada M
    Gan To Kagaku Ryoho; 2016 May; 43(5):571-7. PubMed ID: 27210085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.
    Baxevanis CN; Perez SA; Papamichail M
    Cancer Immunol Immunother; 2009 Mar; 58(3):317-24. PubMed ID: 18704409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Augmentation of antitumor immunity in cancer chemotherapy].
    Hosokawa M; Kobayashi H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1402-6. PubMed ID: 1697151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological aspects of anticancer chemotherapy].
    Zitvogel L; Tesniere A; Apetoh L; Ghiringhelli F; Kroemer G
    Bull Acad Natl Med; 2008 Oct; 192(7):1469-87; discussion 1487-9. PubMed ID: 19445369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits of combining chemotherapy with immuno- oncology therapies or "Is it true that chemotherapy destroys the immune system?"].
    Kocsis J
    Magy Onkol; 2019 Sep; 63(3):202-207. PubMed ID: 31533140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell modulation by cyclophosphamide for tumour therapy.
    Hughes E; Scurr M; Campbell E; Jones E; Godkin A; Gallimore A
    Immunology; 2018 May; 154(1):62-68. PubMed ID: 29460448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapeutic properties of chemotherapy.
    Fournier C; Rivera Vargas T; Martin T; Melis A; Apetoh L
    Curr Opin Pharmacol; 2017 Aug; 35():83-88. PubMed ID: 28551360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological Mechanisms of Low and Ultra-Low Dose Cancer Chemotherapy.
    Landreneau JP; Shurin MR; Agassandian MV; Keskinov AA; Ma Y; Shurin GV
    Cancer Microenviron; 2015 Aug; 8(2):57-64. PubMed ID: 24293116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapy.
    Nars MS; Kaneno R
    Int J Cancer; 2013 Jun; 132(11):2471-8. PubMed ID: 22927096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of correctly timing cancer immunotherapy.
    Beyranvand Nejad E; Welters MJ; Arens R; van der Burg SH
    Expert Opin Biol Ther; 2017 Jan; 17(1):87-103. PubMed ID: 27802061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species in immune cells: A new antitumor target.
    Wang L; Kuang Z; Zhang D; Gao Y; Ying M; Wang T
    Biomed Pharmacother; 2021 Jan; 133():110978. PubMed ID: 33176269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the immune system to the chemotherapeutic response.
    McDonnell AM; Nowak AK; Lake RA
    Semin Immunopathol; 2011 Jul; 33(4):353-67. PubMed ID: 21274535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity.
    Gallo C; Barra G; Saponaro M; Manzo E; Fioretto L; Ziaco M; Nuzzo G; d'Ippolito G; De Palma R; Fontana A
    Mar Drugs; 2020 Nov; 18(12):. PubMed ID: 33260400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer and Immunogenic Properties of Cardiac Glycosides.
    Schneider NFZ; Cerella C; Simões CMO; Diederich M
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29117117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.